Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Synthesis and characterization of a novel Gd-based contrast agent for magnetic resonance imaging of myelination.
"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.
Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
Novel Insights and Therapeutics in Multiple Sclerosis.
A Two Sample Distribution-Free Test for Functional Data with Application to a Diffusion Tensor Imaging Study of Multiple Sclerosis.
Bioactive lignan derivatives from the stems of Firmiana simplex.
Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation.
Longitudinal Functional Data Analysis.
Voltage-gated potassium channel antibodies: Game over.
Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients.
Is it necessary to perform connective tissue disorders laboratory tests when a patient experiences the first demyelinating attack?
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis.
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog.
Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease.
[Emerging new disease--modifying therapies for multiple sclerosis].
Identifying environmental antigens that activate myelin-specific T cells.
Myopathy associated with Neuromyelitis Optica Spectrum Disorders.
Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management.
Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Alternatively activated microglia and macrophages in the central nervous system.
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Genetic manipulation of microglia during brain development and disease.
Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis' views on risks of negative interactions between herbal medicine and conventional drug therapies.
Pages
« first
‹ previous
…
653
654
655
656
657
658
659
660
661
…
next ›
last »